Wang Y, Zhou Y, Khan F
Int J Mol Sci. 2025; 25(24.
PMID: 39769245
PMC: 11677904.
DOI: 10.3390/ijms252413482.
Di Spigna G, Covelli B, Vargas M, Di Caprio R, Rubino V, Iacovazzo C
Life (Basel). 2024; 14(7).
PMID: 39063569
PMC: 11278279.
DOI: 10.3390/life14070814.
Boleslawska I, Kowalowka M, Boleslawska-Krol N, Przyslawski J
Viruses. 2023; 15(6).
PMID: 37376562
PMC: 10326824.
DOI: 10.3390/v15061262.
Ribeiro Dias M, Andriolo B, Silvestre D, Lopes Cascabulho P, Leal da Silva M
Rev Panam Salud Publica. 2023; 47:e21.
PMID: 36686893
PMC: 9847409.
DOI: 10.26633/RPSP.2023.21.
Mathaha T, Mafu M, Mabikwa O, Ndenda J, Hillhouse G, Mellado B
Front Artif Intell. 2022; 5:1013010.
PMID: 36311551
PMC: 9606810.
DOI: 10.3389/frai.2022.1013010.
Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates.
Rodrigues L, Bento Cunha R, Vassilevskaia T, Viveiros M, Cunha C
Molecules. 2022; 27(9).
PMID: 35566073
PMC: 9099573.
DOI: 10.3390/molecules27092723.
A glycosaminoglycan microarray identifies the binding of SARS-CoV-2 spike protein to chondroitin sulfate E.
Watanabe T, Takeda K, Hiemori K, Minamisawa T, Tateno H
FEBS Lett. 2021; 595(18):2341-2349.
PMID: 34375459
PMC: 8427098.
DOI: 10.1002/1873-3468.14173.
Immunoinformatics approach for multi-epitope vaccine design against structural proteins and ORF1a polyprotein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
Adam K
Trop Dis Travel Med Vaccines. 2021; 7(1):22.
PMID: 34238372
PMC: 8266167.
DOI: 10.1186/s40794-021-00147-1.
Impact of COVID-19 Pandemic on Ovarian Cancer Management: Adjusting to the New Normal.
Jacome L, Deshmukh S, Thulasiraman P, Holliday N, Singh S
Cancer Manag Res. 2021; 13:359-366.
PMID: 33469377
PMC: 7813454.
DOI: 10.2147/CMAR.S287152.